In the previous report, the tyrosine kinase inhibitor imantinib methanesulfonate (Gleevec) substantially inhibited PDGFRα-mediated phosphorylation of Akt and HCMV IE expression in human embryonic lung (HEL) cells and U87 glioblastoma cells [31]. This evidence concerns the gene AKT1 and glioblastoma.